Skip to content

Home Grip Assistance Glove on the Use of the Upper Limb and Compliance Factors in Brain-injured Adults

Benefits of a Home Grip Assistance Glove on the Use of the Upper Limb and Compliance Factors in Brain-injured Adults: Comparative Multicenter Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06312631
Acronym
ECO-HAND-AVC
Enrollment
100
Registered
2024-03-15
Start date
2024-03-26
Completion date
2027-12-31
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

brain-injured adult

Brief summary

On a functional level, performing the actions of daily life requires coordinated activity of the muscles of the upper limbs. The quality of motor recovery and/or technical assistance aimed at compensating for the movement deficit of the paretic upper limb (MSP) determines the possibilities of using the upper limb (MS) in activities of daily life. Interventions in the chronic phase of stroke aim to return home. The integration of the paretic upper limb into daily life activities is a major issue regarding the prognosis of recovery of use of the upper limb. Independence in daily life becomes an ultimate goal to take charge of. This study focuses on a new technical aid device, standard orthosis type, expanding the range of gripping gloves: the SaeboGlove in everyday environments. These MS orthoses help improve the use and function of the MSP in post-stroke adults as well as their independence and participation in society.

Interventions

DEVICEPutting on the gripping glove

taking measurements and putting the gripping glove on the patient

OTHERULPA questionnaire

The evaluation of the effectiveness of the gripping glove on the performance of the upper limb in daily life will be evaluated using the ULPA score. The investigator asks the patient to perform a task and the ULPA collects the total number of errors made by the patient (inability/omission, imprecision, repetition, time to complete the task)

OTHERMotor Activity Log (MAL) Questionnaire

The MAL is a self-assessment of the integration of the upper limb into daily life. This measurement allows a quantified evaluation of the perceived performance of the use of the upper limb in the actions of daily life. The patient will answer 30 questions about daily life and for each item, rate the quantity from 0 to 5: 0 = never uses the hemiplegic arm and 5 = uses as much as before the accident

OTHERFugl-Meyer Assessment Upper Extremity (FMA-UE) questionnaire

This questionnaire assesses the motor selectivity of the upper limb. Several questions are asked about the movements that the patient can perform and to each question, the patient can answer either 0 (minimum) and 2 (maximum).

OTHERScore Action Arm Research Test

This questionnaire evaluates 4 different actions: Grasping an object (6 different objects to grasp), holding an object (4 different objects), pinching an object (6 different objects) and the overall movements made by the patient (3 different overall movements). For each item, each object or each movement evaluated, the patient must rate the task on a scale of 0 to 3 (0=cannot perform any part of the test and 3=performs the test normally)

OTHEREuroQol five-level (EQ-5D-5L) questionnaire

This questionnaire assesses the patient's state of health. 5 items are proposed (mobility, autonomy, current activity, pain, anxiety) and for each the patient must check one of the 5 propositions (no problem, mild problems, moderate problems, severe problems, incapable). The patient must also rate their state of health on a scale of 0 to 100.

OTHERQuebec User Evaluation of Satisfaction with Assistive Technology

This questionnaire assesses satisfaction with the technical aid (here the gripping glove) and the related services. The technique and related services will be evaluated by items provided to the patient and he will have to rate for each of them a score between 1 and 5 (1 = not satisfied at all and 5 = very satisfied)

OTHERPsychosocial Impact of Assistive Devices Scale (PIADS)

This questionnaire measures the effect of technical aids on the psychosocial level. 26 sentences or words are offered to the patient concerning his psychological state and the patient must evaluate them between -3 and 3 (-3 = decreased and +3: increased)

OTHERGoal Attainment Scale (GAS)

Carrying out an activity in the patient's real context is assessed using the Goal Attainment Scale (GAS). The doctor gives the patient objectives to achieve and the patient must give the quotation for each objective between initial state (-2), expected result (0) and best possible result (2)

OTHERinstallation and collection of accelerometers

The accelerometer quantitatively reports the spontaneous use of the upper limb in daily life. It counts the number of voluntary movements of the upper limbs. The amount of movement of the paretic upper limb will be expressed as a percentage of the movements of the non-paretic limb.

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patient suffering from a motor deficit of the upper limb resulting from an ischemic or hemorrhagic stroke, hemispheric or brainstem, confirmed by brain imaging ; * Patient who suffered a stroke more than three months ago; * Patient unable to actively extend long fingers (hand opening) to voluntarily grasp an empty glass (upper and lower diameter of 7 and 6 cm respectively, height of 12 to 15 cm, weight of 125g, identical to equipment used for ARAT), with a palmar grip (cylindrical grip), while the subject can hold the previously placed glass passively in the hand; * Patient capable of passively opening the hand sufficient to grasp the glass when the gripping glove is put on, with the possibility of actively closing the hand; * Patient with the ability to put on and remove the SaeboGlove® gripping glove with the help of a third person if necessary and/or available. * Patient with a smartphone, tablet and/or computer compatible with video taking and teleconsultation. * Free, informed and signed consent by the participant and/or the person having guardianship and the investigator (at the latest on the day of inclusion and before any examination required by the research); * Person affiliated to or beneficiary of a social security system.

Exclusion criteria

* Patient presenting retraction or stiffness of the fingers and wrist preventing complete extension of the long fingers and thumb, the wrist being at 15° extension; * Patient with moderate or severe muscular spasticity of the wrist flexors and the long and short flexors of the fingers and thumb (Modified Ashworth Scale ≥ 3); * Patient with limited active elbow extension, not allowing the ipsilateral knee to be reached with the hand, the subject being seated with the trunk vertical (approach limitation); * Patient with an active anterior shoulder elevation range of less than 15°; * Patient with other upper limb deficiencies likely to influence participation; * Patient and/or entourage who do not have access to teleconsultation, and/or can be reached remotely; * Patient with severe aphasia, Boston Diagnostic Aphasia Examination (BDAE) ≤ 3; * Presence of moderate or severe edema localized to the wrist and hand; * Patient allergic to Latex * History of upper limb surgery less than 6 months old. * Pregnant and/or breastfeeding women * Patient deprived of liberty (detained/incarcerated); * Patient under judicial protection * Impossibility of giving the person informed information and ensuring the subject's compliance due to impaired physical and/or psychological health

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the effectiveness of the gripping glove6 monthsThe evaluation of the effectiveness of the gripping glove on the performance of the upper limb in daily life will be evaluated using the ULPA score and compared between the 2 conditions (with and without the glove) in the performance of a daily activity.

Secondary

MeasureTime frameDescription
Evaluation of the performance of an activity in the real context of the patient6 monthsThe performance of an activity in the real context of the patient will be evaluated using the GAS. Information is collected from the person and/or their entourage at each visit, assessed during visits T1 (14 days), T2 (3 months) and T3 (6 months) by the assessor (occupational therapist) from each center.
Evaluation of factual spontaneous use of the upper limb in daily life6 monthsFactual spontaneous use of the upper limb in daily life will be measured using a wrist accelerometer. The movement will be compared between T0, T2 (3 months) and T3 (6 months).
Evaluation of the perceived performance of the use of the paretic upper limb6 monthsThe perceived performance of the use of the paretic upper limb will be evaluated using the MAL at T0, T2 (3 months) and T3 (6 months).
Assessment of the quality of voluntary motor skills of the upper limb6 monthsThe quality of voluntary motor skills of the upper limb will be assessed with the FMA at T0, T2 (3 months) and T3 (6 months), without wearing the gripping glove.
Assessment of gripping abilities6 monthsGrasping abilities will be assessed by the ARAT at T0, T2 (3 months) and T3 (6 months), without wearing the gripping glove.
Quality of life assessment6 monthsQuality of life, assessed using the EQ-5D-5L, will be explored at T0, T2 (3 months) and T3 (6 months).
Evaluation of satisfaction and tolerance6 monthsSatisfaction and tolerance will be assessed by the patient with the QUEST version 2.0 questionnaire, at the end of the T3 visit (6 months).
Evaluation of the psycho-social impact6 monthsThe psycho-social impact will be assessed with the F-PIADS questionnaire during visits to T2 (3 months) T3 (6 months), by the evaluator (occupational therapist) from each center.

Countries

France

Contacts

CONTACTClaire VILLEPINTE
villepinte.c@chu-toulouse.fr0567771724
CONTACTAudrey TOMASIK
tomasik.a@chu-toulouse.fr0561778597
PRINCIPAL_INVESTIGATORClaire VILLEPINTE

University Hospital, Toulouse

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026